Subsequent Event - Additional Information (Details) - Subsequent Event - Pfizer Inc Merger Agreement $ / shares in Units, $ in Millions	Aug. 07, 2022 USD ($) $ / shares
Subsequent Event [Line Items]
Termination fee	$ 217
Stock converted right to receive in cash consideration \| $ / shares	$ 68.50
Reverse termination fee	$ 326

Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.

No definition available.

Name:	us-gaap_SubsequentEventLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration